Diabetic Comorbidity and MERS Coronavirus Pathogenesis
Diabetic Comorbidity and MERS Coronavirus Pathogenesis
批准号:
9294969
负责人:
Matthew Bryan Frieman
金额:
$19.54万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-13 至 2018-05-31
关键词:
AffectAnimal ModelBrainCamelsCase Fatality RatesCase StudyCessation of lifeChinese PeopleChiropteraClinicalClinical DataCommunitiesComorbidityCoronaviridaeCoronavirusCoronavirus InfectionsCountryDevelopmentDiabetes MellitusDiabetic mouseDipeptidyl-Peptidase IVDiseaseDisease OutbreaksDrug TargetingEndopeptidasesFDA approvedFutureGCG geneGlareGlucoseGovernmentHealth PersonnelHeart DiseasesHospitalsHumanImmune responseImmunosuppressionInfectionInflammatory ResponseInsulinJordanKidney FailureKnowledgeLeadLifeLungMiddle EastMiddle East Respiratory Syndrome CoronavirusMusNeurotransmittersNon-Insulin-Dependent Diabetes MellitusOutcomePathogenesisPathogenicityPatientsPersonsProteinsPublic HealthRoleSaudi ArabiaSouth KoreaSyndromeT-LymphocyteTestingVirusVirus ReplicationViverridaeWorkblood glucose regulationchemokinecohortcomparativecoronavirus receptorcytokinediabeticin vivoinhibitor/antagonistmacrophagemonocytemouse modelnovelpermissivenessreceptorrespiratoryrespiratory virustransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Here we seek to identify the role of diabetes in Middle East Respiratory Syndrome
Coronavirus (MERS-CoV) pathogenesis. MERS-CoV emerged in 2012 in Saudi Arabia
leading to over 1700 infections with a ~40% case fatality rate. The majority of lethal
MERS-CoV infections are associated with comorbidity, with diabetes as the top
comorbidity. We will use a mouse model of MERS-CoV to identify if preexisting Type 2
diabetes exacerbates MERS-CoV disease, how diabetes alters the inflammatory response
and protection from MERS-CoV and if drugs targeting a regulator of diabetes can
protect mice from MERS-CoV.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/infdis/jiab036
发表时间:
2022-05-16
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[Sivapalasingam S, Saviolakis GA, Kulcsar K, Nakamura A, Conrad T, Hassanein M, Sumner G, Elango C, Kamal MA, Eng S, Kyratsous CA, Musser BJ, Frieman M, Kantrowitz J, Weinreich DM, Yancopoulos G, Stahl N, Lipsich L]
通讯作者:
Lipsich L
Coronavirus Challenge Core
-
批准号:10420513
-
项目类别:
-
资助金额:$144.15万
-
财政年份:2022
-
负责人:Matthew Bryan Frieman
-
依托单位:
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
-
批准号:10183158
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10649491
-
项目类别:
-
资助金额:$55.08万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10196973
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10418670
-
项目类别:
-
资助金额:$55.24万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
-
批准号:10038144
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8878023
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8290205
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8683089
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:9275569
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8161787
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8500163
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Inhibition of the Innate Immune Response by the SARS Coronavirus
-
批准号:7874578
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Matthew Bryan Frieman
-
依托单位:
Inhibition of the Innate Immune Response by the SARS Coronavirus
-
批准号:7532181
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2009
-
负责人:Matthew Bryan Frieman
-
依托单位:
SARS-CoV Mediated Modulation of Innate Immunity
-
批准号:7266327
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2005
-
负责人:Matthew Bryan Frieman
-
依托单位:
SARS-CoV Mediated Modulation of Innate Immunity
-
批准号:6997685
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Matthew Bryan Frieman
-
依托单位:
SARS-CoV Mediated Modulation of Innate Immunity
-
批准号:7099465
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Matthew Bryan Frieman
-
依托单位:
海外基金